The Week In... Pharma (08-12/07)
  • Posted on: 12/07/2019
  • Category: Industry

The Week In... Pharma (08-12/07)

A subscription-style payment model is launched to incentivise R&D in pharma and biotech, the NHS offers £750k for a company to help combat alleged pharmacy fraud, and the UK government sets aside £3 million to transport short-life medicines and devices in a no-deal Brexit.

Interested in Star’s innovative outsourcing and resourcing solutions?

Contact Head of Business Development, Ryan Wooller, at, or get in touch on 07748 464 079.

On the hunt for a new role, or just curious?

Visit our candidate page, submit your CV to, or give our offices a ring!

UK launches subscription-style payment pilot to incentivise pharma antibiotics R&D

The UK is to try out a subscription-style payment model aimed at incentivising pharma and biotech companies to develop new drugs needed to tackle resistant infections.

Government tenders for £3m contract for Brexit medicines express

The government has set aside £3m to transport short-life medicines and medical devices in the event of a no-deal Brexit.

Making patient involvement meaningful

How do we move patient engagement from case studies to metrics, does meaningful mean measurable, and what does it matter anyway? These were among the questions at the Pioneering Partnerships conference.

Ruffels leaves Samsung for GSK

Zoe Ruffels, vice-president of European consumer and market insights at Samsung Electronics, is leaving the business to join GSK Consumer Healthcare.

NHS to pay company £750k to crack down on alleged pharmacy fraud

The NHS Business Services Authority (NHS BSA) is offering to pay up to £750,000 for a “predictive analytics partner” to help combat alleged pharmacy fraud.

While you’re here…

…and are interested in our content, why not sign up to our newsletter?

It’s just below here.